Validation pour Ingenuity226

vers la météo de la validation par utilisateur

Ingenuity226

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 17 - PMID ?

In female adult SP missing a ovary , subcutaneous injection of NODE protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |                                      |                             |                       +------------COMP:N-N(of)------------+       |                                                                   +--------------COMP:V_PASS-N(by)-------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V_PASS-N-----------------+            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 1

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |               +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+--------------------------------------------------COMP:V-N(by)--------------------------------------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                   |      +------------------------SUBJ:V_PASS-N-----------------------+                                            |        
                    |               |                                                    |                       +------------COMP:N-N(of)------------+       |      +------COMP:N-N(in)-----+                                    |                                            |        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V_PASS-N-----------------+                                            |        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(by) (cause,bisphosphonate)
COMP:N-N(in) (little,formation)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,little)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 2

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+      +------------------------SUBJ:V_PASS-N-----------------------+                                                     
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |      +------COMP:N-N(in)-----+                                    +--------------COMP:V_PASS-N(by)-------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V_PASS-N-----------------+            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (little,formation)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,little)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 3

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |                                      |                             |                       +------------COMP:N-N(of)------------+       +--------------------------------------------------COMP:V-N(by)--------------------------------------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V_PASS-N-----------------+            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(by) (cause,bisphosphonate)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 4

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |               +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+                                                                                                                         
                    |               |                                                    +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |               |                                                    |                       +------------COMP:N-N(of)------------+       +--------------------------------------------------COMP:V-N(by)--------------------------------------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V_PASS-N-----------------+                                            |        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(by) (cause,bisphosphonate)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 5

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |                                      |                             |                       +------------COMP:N-N(of)------------+       |                                                                                                                         
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V_PASS-N-----------------+--------------COMP:V_PASS-N(by)-------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 6

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |      +-------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                                                                                                                         
                    |      |                                                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +--------------------SUBJ:V-N-------------------+-------------------OBJ:V-N------------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                                    +COMP:V-N+                  +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |        |                  |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,miss)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (decrease,change)
COMP:V-N(by) (decrease,3)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 7

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |               +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+                                                                                                                         
                    |               |                                                    +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +--------------------SUBJ:V-N-------------------+-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                                    +COMP:V-N(by)+              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (decrease,change)
COMP:V-N(by) (decrease,amino)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 8

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |      +-------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                                                                                                                         
                    |      |                                                             +---------------------OBJ:V-N--------------------+                   |      +--------------------------SUBJ:V-N--------------------------+                                                     
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+--------------------SUBJ:V-N-------------------+-------------------OBJ:V-N------------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    +COMP:V-N(by)+              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,miss)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (decrease,little)
SUBJ:V-N (decrease,change)
COMP:V-N(by) (decrease,amino)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 9

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |      +-------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                                                                                                                         
                    |      |                                                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |      |                                                             |                       +------------COMP:N-N(of)------------+       |                                                                                                                         
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+--------------------SUBJ:V-N-------------------+-------------------OBJ:V-N------------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    +COMP:V-N+                  +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |        |                  |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,miss)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (decrease,change)
COMP:V-N(by) (decrease,3)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 10

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+--------------------SUBJ:V-N-------------------+-------------------OBJ:V-N------------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    +COMP:V-N+                  +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |        |                  |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (decrease,change)
COMP:V-N(by) (decrease,3)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 11

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |      +-------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                                                                                                                         
                    |      |                                                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+--------------------SUBJ:V-N-------------------+-------------------OBJ:V-N------------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    +COMP:V-N+                  +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |        |                  |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,miss)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (decrease,change)
COMP:V-N(by) (decrease,3)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 12

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |                                      |                             |                       +------------COMP:N-N(of)------------+       |                   +----------------------------------------COMP:N-N(by)----------------------------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V_PASS-N-----------------+                                            |        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
COMP:N-N(by) (change,bisphosphonate)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 13

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                   +----------------------------------------COMP:N-N(by)----------------------------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V_PASS-N-----------------+            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
COMP:N-N(by) (change,bisphosphonate)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 14

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |                                      |                             |                       +------------COMP:N-N(of)------------+       |                   +-----------------SUBJ:V_PASS-N-----------------+                                                     
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V-N----------------+     +--------------COMP:V_PASS-N(by)-------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 15

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |      +-------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                                                                                                                         
                    |      |                                                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |      |                                                             |                       +------------COMP:N-N(of)------------+       |                   +-----------------SUBJ:V_PASS-N-----------------+                                                     
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V-N----------------+     +--------------COMP:V_PASS-N(by)-------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,miss)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 16

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |               +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+                                                                                                                         
                    |               |                                                    +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |               |                                                    |                       +------------COMP:N-N(of)------------+       |                   +-----------------SUBJ:V_PASS-N-----------------+--------------COMP:V_PASS-N(by)-------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                              |     |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                              |     |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 17

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |                                      |                             |                       +------------COMP:N-N(of)------------+       +--------------------------------------------------COMP:V-N(by)--------------------------------------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V_PASS-N-----------------+            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,change)
COMP:V-N(by) (cause,bisphosphonate)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 18

                    +-------------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------------+                                                     
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                                       |                                                     
                    |                                                                    |                       +------------COMP:N-N(of)------------+                           +--------------------SUBJ:V-N-------------------+-------------------OBJ:V-N------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     +COMP:V-N+   |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |        |   |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,change)
COMP:V-N(by) (decrease,3)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 19

                    +-------------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------------+                                                     
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                                       |                                                     
                    |                                                                    |                       +------------COMP:N-N(of)------------+                           +--------------------SUBJ:V-N-------------------+-------------------OBJ:V-N------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     +COMP:V-N+   |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |        |   |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,change)
COMP:V-N(by) (decrease,3)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 20

                                                                                         +---------------------OBJ:V-N--------------------+                          +-----------------------SUBJ:V-N-----------------------+                                                           
                                                                                         |                       +------------COMP:N-N(of)------------+              |            +-----------------SUBJ:V-N----------------+                                                           
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+              +------COMP:N-N(in)-----+                              |     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+              |            +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |              |            |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (little,formation)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,little)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 21

                                                                                         +---------------------OBJ:V-N--------------------+                          +-----------------------SUBJ:V-N-----------------------+                                                           
                                                                                         |                       +------------COMP:N-N(of)------------+              |            +-----------------SUBJ:V-N----------------+                                                           
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+              +------COMP:N-N(in)-----+                              |     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+              |            +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |              |            |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (little,formation)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,little)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 22

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +---------COMP:N-N(in)---------+                                    +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       |                   +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (cause,formation)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 23

                    +-------------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------------+                                                     
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                                       |                                                     
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +--------------------SUBJ:V-N-------------------+-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    +COMP:V-N+                  +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |        |                  |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,change)
COMP:V-N(by) (decrease,3)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 24

                    +-------------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------------+                                                     
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                                       |                                                     
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +--------------------SUBJ:V-N-------------------+-------------------OBJ:V-N------------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    +COMP:V-N(by)+              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,change)
COMP:V-N(by) (decrease,amino)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 25

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                           +-------------------OBJ:V-N------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 26

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+              +-----------------------SUBJ:V-N-----------------------+     +-------------------OBJ:V-N------------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+              |            +-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+              |            +COMP:N-N(i+                              |     |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |              |            |          |                              |     |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,little)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 27

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                           +-------------------OBJ:V-N------------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 28

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |               +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+                                                                                                                         
                    |               |                                                    +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |               |                                                    |                       +------------COMP:N-N(of)------------+       |      +------------------------SUBJ:V_PASS-N-----------------------+--------------COMP:V_PASS-N(by)-------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V_PASS-N-----------------+            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,little)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 29

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |      +-------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+--------------------------------------------------COMP:V-N(by)--------------------------------------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                   |      +------------------------SUBJ:V_PASS-N-----------------------+                                            |        
                    |      |                                                             |                       +------------COMP:N-N(of)------------+       |      |            +-----------------SUBJ:V_PASS-N-----------------+                                            |        
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V-N----------------+     |                                            |        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,miss)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(by) (cause,bisphosphonate)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,little)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 30

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |      +-------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+--------------------------------------------------COMP:V-N(by)--------------------------------------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                   |      +------------------------SUBJ:V_PASS-N-----------------------+                                            |        
                    |      |                                                             |                       +------------COMP:N-N(of)------------+       |      |            +-----------------SUBJ:V_PASS-N-----------------+                                            |        
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                              |     |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                              |     |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,miss)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(by) (cause,bisphosphonate)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,little)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 31

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 32

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 33

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                           +-------------------OBJ:V-N------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 34

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                           +-------------------OBJ:V-N------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 35

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                           +-------------------OBJ:V-N------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 36

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 37

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 38

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |                                      |                             |                       +------------COMP:N-N(of)------------+       +--------------------------------------------------COMP:V-N(by)--------------------------------------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V_PASS-N-----------------+                                            |        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(by) (cause,bisphosphonate)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 39

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+      +------------------------SUBJ:V_PASS-N-----------------------+                                                     
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |      |            +-----------------SUBJ:V_PASS-N-----------------+                                                     
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V-N----------------+     +--------------COMP:V_PASS-N(by)-------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,little)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 40

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |      +-------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                                                                                                                         
                    |      |                                                             +---------------------OBJ:V-N--------------------+                   |      +------------------------SUBJ:V_PASS-N-----------------------+                                                     
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V_PASS-N-----------------+--------------COMP:V_PASS-N(by)-------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,miss)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,little)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 41

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 42

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 43

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 44

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 45

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                       +-------------------OBJ:V-N------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 46

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |                                      |                             |                       +------------COMP:N-N(of)------------+       |                   +-----------------SUBJ:V_PASS-N-----------------+--------------COMP:V_PASS-N(by)-------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                              |     |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                              |     |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 47

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 48

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 49

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 50

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 51

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 52

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+              +-----------------------SUBJ:V-N-----------------------+                                                           
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+              |            +-----------------SUBJ:V-N----------------+     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+              |            +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |              |            |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,little)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 53

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 54

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 55

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                       +-------------------OBJ:V-N------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 56

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 57

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                       +-------------------OBJ:V-N------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 58

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                       +-------------------OBJ:V-N------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 59

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 60

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                           +-----------------SUBJ:V-N----------------+     +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 61

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                       +-------------------OBJ:V-N------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 62

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+                                                                           +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+                           +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |                           |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 63

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                           +-------------------OBJ:V-N------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +---------COMP:N-N(in)---------+                                    |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       |                   +COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (cause,formation)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 64

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +---------COMP:N-N(in)---------+                                    +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       |                   +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (cause,formation)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 65

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
                                                                                         |                       +------------COMP:N-N(of)------------+                                                                                                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+              +------COMP:N-N(in)-----+                                    +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+              |            +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |              |            |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (little,formation)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 66

                                                                                         +---------------------OBJ:V-N--------------------+                                                                                                                                             
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+              +------COMP:N-N(in)-----+                                    +-------------------OBJ:V-N------------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+              |            +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |              |            |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:N-N(in) (little,formation)
COMP:N-N(in) (change,formation)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 67

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |                                      |                             |                       +------------COMP:N-N(of)------------+       |                   +----------------------------------------COMP:N-N(by)----------------------------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V_PASS-N-----------------+            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                                    |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
COMP:N-N(by) (change,bisphosphonate)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 68

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |                                      +---------------------------------------------SUBJ:V-N---------------------------------------------+                                                                                                                         
                    |                                      |                             +---------------------OBJ:V-N--------------------+                   |                   +----------------------------------------COMP:N-N(by)----------------------------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+       |                   +-----------------SUBJ:V_PASS-N-----------------+                                            |        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V-N----------------+     |                                            |        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,injection)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
COMP:N-N(by) (change,bisphosphonate)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 69

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |      +-------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                                                                                                                         
                    |      |                                                             +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
                    |      |                                                             |                       +------------COMP:N-N(of)------------+       |                   +----------------------------------------COMP:N-N(by)----------------------------------------+        
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V_PASS-N-----------------+                                            |        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,miss)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
COMP:N-N(by) (change,bisphosphonate)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 70

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |               +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+                                                                                                                         
                    |               |                                                    +---------------------OBJ:V-N--------------------+                   |                   +----------------------------------------COMP:N-N(by)----------------------------------------+        
                    |               |                                                    |                       +------------COMP:N-N(of)------------+       |                   +-----------------SUBJ:V_PASS-N-----------------+                                            |        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V-N----------------+     |                                            |        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                              |     |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                              |     |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
COMP:N-N(by) (change,bisphosphonate)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 71

                    +---------------------------------------------------------------COMP:V-N(In)--------------------------------------------------------------+                                                                                                                         
                    |               +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+                                                                                                                         
                    |               |                                                    +---------------------OBJ:V-N--------------------+                   |                   +----------------------------------------COMP:N-N(by)----------------------------------------+        
                    |               |                                                    |                       +------------COMP:N-N(of)------------+       |                   +-----------------SUBJ:V_PASS-N-----------------+                                            |        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                              |     |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                              |     |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,__SP__)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
COMP:N-N(by) (change,bisphosphonate)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 72

                           +-----------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                                                                                                                         
                           |        +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+                                                                                                                         
       +----MOD_ATT:N-N----+        |                                                    +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       |                   +-----------------SUBJ:V_PASS-N-----------------+--------------COMP:V_PASS-N(by)-------------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +------OBJ:V-N------+COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |                   |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,miss)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 73

                           +-----------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                                                                                                                         
                           |        +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+                                                                                                                         
                           |        |                                                    +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
       +----MOD_ATT:N-N----+        |                                                    |                       +------------COMP:N-N(of)------------+       |      +--------------------------SUBJ:V-N--------------------------+                                                     
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+--------------------SUBJ:V-N-------------------+-------------------OBJ:V-N------------------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    +COMP:V-N(by)+              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,miss)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (decrease,little)
SUBJ:V-N (decrease,change)
COMP:V-N(by) (decrease,amino)
OBJ:V-N (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 74

                           +-----------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                                                                                                                         
                           |        +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+                                                                                                                         
                           |        |                                                    +---------------------OBJ:V-N--------------------+                   |                                                                                                                         
       +----MOD_ATT:N-N----+        |                                                    |                       +------------COMP:N-N(of)------------+       |      +------------------------SUBJ:V_PASS-N-----------------------+                                                     
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V_PASS-N-----------------+--------------COMP:V_PASS-N(by)-------------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                                    |                           +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                                    |                           |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,miss)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V_PASS-N (decrease,little)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 75

                           +-----------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                                                                                                                         
                           |        +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+                                                                                                                         
                           |        |                                                    +---------------------OBJ:V-N--------------------+                   |      +------------------------SUBJ:V_PASS-N-----------------------+                                                     
       +----MOD_ATT:N-N----+        |                                                    |                       +------------COMP:N-N(of)------------+       |      |            +-----------------SUBJ:V_PASS-N-----------------+--------------COMP:V_PASS-N(by)-------------+        
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                              |     |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                              |     |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,miss)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,little)
SUBJ:V_PASS-N (decrease,change)
COMP:V_PASS-N(by) (decrease,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 76

                           +-----------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+--------------------------------------------------COMP:V-N(by)--------------------------------------------------+        
                           |        +---------------------------------------------------------SUBJ:V-N--------------------------------------------------------+      +------------------------SUBJ:V_PASS-N-----------------------+                                            |        
       +----MOD_ATT:N-N----+        |                                                    +---------------------OBJ:V-N--------------------+                   |      |            +-----------------SUBJ:V_PASS-N-----------------+                                            |        
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+       +------OBJ:V-N------+-----------------SUBJ:V-N----------------+     |            +----------MOD_ATT:N-N----------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+       +OBJ:V-+            +COMP:N-N(i+                              |     |            |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |       |      |            |          |                              |     |            |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) causes little or no change in formation to trabecular bone that is decreased by 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (cause,miss)
SUBJ:V-N (cause,ovary)
OBJ:V-N (cause,little)
OBJ:V-N (cause,change)
COMP:V-N(by) (cause,bisphosphonate)
COMP:N-N(in) (change,formation)
SUBJ:V-N (be,change)
SUBJ:V_PASS-N (decrease,little)
SUBJ:V_PASS-N (decrease,change)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)